For all whole exome and whole genome sequencing tests performed at MNG, we offer a complete data reassessment. We re-evaluate all of the aligned sequencing data as if it has not yet been evaluated by re-classifying all sequencing variants using our MNG Genome Manager® analysis pipeline. The clinical reporting team reviews all variants to assess for any classification updates or newly relevant variants and re-examines copy number data. An updated proband report will be provided even if no changes are found.
All MNG Exome and MNGenome® reports are eligible for a no-cost, full data reassessment 6 months after the initial report date and once per 12 month period thereafter. Reassessments are available indefinitely, but are limited to the data generated when the original sequencing was performed.
Please use the Internal Data Reassessment Form for all reassessment requests. The attached consent form is required due to incidental findings that may arise, or pathogenic changes that may be newly reported.
We encourage any new or updated clinical information to be submitted with the Data Reassessment request as it may help with variant interpretation. Please also include any additional testing that has been performed on the proband or family members.
Please allow up to 4 weeks for an updated report to be generated and sent to the designated parties.